Schonfeld Strategic Advisors LLC Aim Immuno Tech Inc. Transaction History

Schonfeld Strategic Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.78 - $1.27 $8,424 - $13,716	-10,800 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.67 - $1.18 $201 - $354	-300 Reduced 2.7%	10,800 $11,000
Q4 2021 Feb 14, 2022	SELL	$0.92 - $1.96 $92 - $196	-100 Reduced 0.89%	11,100 $10,000
Q3 2021 Nov 16, 2021	SELL	$1.91 - $2.17 $22,729 - $25,823	-11,900 Reduced 51.52%	11,200 $23,000
Q2 2021 Aug 16, 2021	SELL	$1.93 - $2.39 $29,722 - $36,806	-15,400 Reduced 40.0%	23,100 $49,000
Q1 2021 May 17, 2021	BUY	$1.88 - $2.82 $72,380 - $108,570	38,500 New	38,500 $88,000

9.01M

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $10.1M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.